Anthracycline analogs: the past, present, and future.
D000818:Animals; D000903:Antibiotics, Antineoplastic / Q000627:therapeutic use*; D009202:Cardiomyopathies / Q000139:chemically induced; D002986:Clinical Trials as Topic; D003630:Daunorubicin / Q000009:adverse effects / Q000031:analogs & derivatives* / Q000378:metabolism / Q000627:therapeutic use; D004317:Doxorubicin / Q000009:adverse effects / Q000031:analogs & derivatives* / Q000378:metabolism / Q000627:therapeutic use*; D015251:Epirubicin; D005260:Female; D006168:Guinea Pigs; D006321:Heart / Q000187:drug effects; D006801:Humans; D015255:Idarubicin; D008297:Male; D017290:Menogaril; D051379:Mice; D009621:Nogalamycin / Q000009:adverse effects / Q000031:analogs & derivatives / Q000378:metabolism / Q000627:therapeutic use*; D011817:Rabbits; D051381:Rats
D000903:Antibiotics, Antineoplastic; D015251:Epirubicin; D004317:Doxorubicin; D017290:Menogaril; D009621:Nogalamycin; C030851:esorubicin; D015255:Idarubicin; D003630:Daunorubicin